Source: Annual Congress 2007 - Infectious lung and pleural diseases
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
K. Bogats‘ka, K. Gashynova, T. Onyshchenko (Dnipropetrovs‘k, Ukraine). Nosocomial pneumonia: influence of smoking on the course of disease. Eur Respir J 2007; 30: Suppl. 51, 2719

Member's Comments

No comment yet.

Related content which might interest you: The tobacco-smoking influence on the community-acquired pneumonia course Source: Eur Respir J 2006; 28: Suppl. 50, 247s Year: 2006 Nosocomial pneumonia: most frequent infecting agents and patients‘ smoking status Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia Year: 2007 The impact of smoking on community acquired pneumonia course and outcomes Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 The influence of anxiety on the behavior of smoking in patients with community-acquired pneumonia Source: International Congress 2016 – Smoking-related diseases Year: 2016 Nosocomial pneumonia: treatment and prevention Source: Annual Congress 2004 - PG22 - New perspectives in pneumonia treatment and prophylaxis Year: 2004 The tobacco smoking prolongation and intensity influence on the community-acquired pneumonia course Source: Eur Respir J 2004; 24: Suppl. 48, 153s Year: 2004 The prevalence of smoking in HIV-infected patients with community-acquired pneumonia Source: International Congress 2015 – Epidemiology, public health and economics of tobacco Year: 2015 Effect of smoking on prognosis and mortality in patients hospitalized due to community acquired pneumonia Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 The influence of smoking habit in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2003; 22: Suppl. 45, 149s Year: 2003 The main risk factors of the community-acquired pneumonia delayed course Source: Eur Respir J 2005; 26: Suppl. 49, 643s Year: 2005 Burden and impact of hospital-acquired infections in patients with chronic lung disease Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption Year: 2016 Factors associated with unknown aetiology in patients with community-acquired pneumonia Source: Eur Respir J 2002; 20: 1254-1262 Year: 2002 Influence of comorbidities on pneumococcal community-acquired pneumonia Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013 Prevention is better than cure: time to change the focus of community-acquired pneumonia management Source: Eur Respir J 2015; 45: 1524-1525 Year: 2015 Healthcare-associated pneumonia: Comparative characteristics with community-acquired pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 Treatment failure of community-acquired pneumonia: risk factors and consequences Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections Year: 2012 Epidemiology of community-acquired pneumonia and nosocomial pneumonia Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Risk factors for early onset severe community-acquired pneumonia complications Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ? Year: 2018 COPD: what is the frequency and impact of community-acquired pneumonia? Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know? Year: 2008 Risk factors of community-acquired pneumonia in children Source: Eur Respir J 2010; 36: 1221-1222 Year: 2010